JP2012528867A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012528867A5 JP2012528867A5 JP2012514047A JP2012514047A JP2012528867A5 JP 2012528867 A5 JP2012528867 A5 JP 2012528867A5 JP 2012514047 A JP2012514047 A JP 2012514047A JP 2012514047 A JP2012514047 A JP 2012514047A JP 2012528867 A5 JP2012528867 A5 JP 2012528867A5
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- nucleotide
- guanosine
- deaza
- cytosine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US18292809P | 2009-06-01 | 2009-06-01 | |
| US61/182,928 | 2009-06-01 | ||
| PCT/US2010/036923 WO2010141483A2 (en) | 2009-06-01 | 2010-06-01 | Potentiation of autoimmune and inflammatory disease treatments by immune regulatory oligonucleotide (iro) antagonists of tlr7 and tlr9 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012528867A JP2012528867A (ja) | 2012-11-15 |
| JP2012528867A5 true JP2012528867A5 (enExample) | 2017-09-07 |
| JP6275380B2 JP6275380B2 (ja) | 2018-02-07 |
Family
ID=43298446
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012514047A Expired - Fee Related JP6275380B2 (ja) | 2009-06-01 | 2010-06-01 | Ｔｌｒ７およびｔｌｒ９の免疫調節オリゴヌクレオチド（ｉｒｏ）アンタゴニストによる自己免疫および炎症性疾患治療の強化 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US8987221B2 (enExample) |
| EP (1) | EP2437791B1 (enExample) |
| JP (1) | JP6275380B2 (enExample) |
| CN (1) | CN102612561A (enExample) |
| CA (1) | CA2762206C (enExample) |
| ES (1) | ES2624767T3 (enExample) |
| WO (1) | WO2010141483A2 (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100233270A1 (en) | 2009-01-08 | 2010-09-16 | Northwestern University | Delivery of Oligonucleotide-Functionalized Nanoparticles |
| EP3213770B1 (en) | 2010-11-19 | 2021-02-24 | Idera Pharmaceuticals, Inc. | Immune regulatory oligonucleotide (iro) compounds to modulate toll-like receptor based immune response |
| DE202012013155U1 (de) * | 2011-10-10 | 2015-02-06 | Abbvie Biotechnology Ltd. | System zur Verwaltung von Gesundheitsdiensten |
| EP2852388A4 (en) * | 2012-05-23 | 2016-01-13 | Univ Johns Hopkins | COMPOUNDS AND METHOD FOR USE THEREOF FOR THE TREATMENT OF NEURODEEGENERATIVE DISEASES |
| KR102027023B1 (ko) | 2012-11-29 | 2019-09-30 | 에스비아이 바이오테크 가부시키가이샤 | 저해성 올리고뉴클레오티드 및 그의 용도 |
| WO2014110081A1 (en) * | 2013-01-08 | 2014-07-17 | Idera Pharmaceuticals, Inc. | Immune regulatory oligonucleotide (iro) compounds to modulate toll-like receptor based immune response |
| EP2754714A1 (en) * | 2013-01-14 | 2014-07-16 | Sarepta Therapeutics, Inc. | Inhibitory oligonucleotides and their use in therapy |
| US11213593B2 (en) | 2014-11-21 | 2022-01-04 | Northwestern University | Sequence-specific cellular uptake of spherical nucleic acid nanoparticle conjugates |
| WO2017173334A1 (en) | 2016-04-01 | 2017-10-05 | Checkmate Pharmaceuticals, Inc. | Fc receptor-mediated drug delivery |
| CN114807152A (zh) | 2016-06-08 | 2022-07-29 | 哈佛学院院长及董事 | 工程化病毒载体减少了炎症和免疫反应的诱导 |
| WO2018039629A2 (en) | 2016-08-25 | 2018-03-01 | Northwestern University | Micellar spherical nucleic acids from thermoresponsive, traceless templates |
| US11433131B2 (en) | 2017-05-11 | 2022-09-06 | Northwestern University | Adoptive cell therapy using spherical nucleic acids (SNAs) |
| EP3707262A1 (en) | 2017-11-08 | 2020-09-16 | President and Fellows of Harvard College | Compositions and methods for inhibiting viral vector-induced inflammatory responses |
| US12246031B2 (en) | 2018-02-13 | 2025-03-11 | Checkmate Pharmaceuticals, Inc. | Compositions and methods for tumor immunotherapy |
| MX2020010410A (es) | 2018-04-09 | 2021-01-15 | Checkmate Pharmaceuticals | Empaquetado de oligonucleotidos en particulas similares a virus. |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5399676A (en) * | 1989-10-23 | 1995-03-21 | Gilead Sciences | Oligonucleotides with inverted polarity |
| US6096722A (en) * | 1990-08-14 | 2000-08-01 | Isis Pharmaceuticals Inc. | Antisense modulation of cell adhesion molecule expression and treatment of cell adhesion molecule-associated diseases |
| US7276489B2 (en) * | 2002-10-24 | 2007-10-02 | Idera Pharmaceuticals, Inc. | Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ ends |
| US7973016B2 (en) | 2004-01-23 | 2011-07-05 | Joslin Diebetes Center | Methods of treating, reducing, or preventing autoimmune conditions |
| JP2009510096A (ja) * | 2005-09-27 | 2009-03-12 | コーリー ファーマシューティカル ゲーエムベーハー | アダプターオリゴヌクレオチドを用いたｔｌｒ媒介免疫応答の調節 |
| US8383598B2 (en) * | 2005-10-12 | 2013-02-26 | Idera Pharmaceuticals, Inc. | Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response |
| EP2341059A1 (en) * | 2005-10-12 | 2011-07-06 | Idera Pharmaceuticals, Inc. | Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response |
| US8426375B2 (en) * | 2005-10-12 | 2013-04-23 | Idera Pharmaceuticals, Inc. | Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response |
| PL2154144T3 (pl) | 2008-08-06 | 2015-04-30 | Changchun Huapu Biotechnology Co Ltd | Oligonukleotydy i ich zastosowanie |
-
2010
- 2010-06-01 CA CA2762206A patent/CA2762206C/en active Active
- 2010-06-01 EP EP10783933.4A patent/EP2437791B1/en not_active Not-in-force
- 2010-06-01 CN CN2010800243380A patent/CN102612561A/zh active Pending
- 2010-06-01 US US12/791,636 patent/US8987221B2/en active Active
- 2010-06-01 WO PCT/US2010/036923 patent/WO2010141483A2/en not_active Ceased
- 2010-06-01 JP JP2012514047A patent/JP6275380B2/ja not_active Expired - Fee Related
- 2010-06-01 ES ES10783933.4T patent/ES2624767T3/es active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012528867A5 (enExample) | ||
| JP2010536787A5 (enExample) | ||
| JP6406793B2 (ja) | トール様受容体に基づく免疫反応を調整する免疫調節ヌクレオチド（ｉｒｏ）化合物 | |
| JP6275380B2 (ja) | Ｔｌｒ７およびｔｌｒ９の免疫調節オリゴヌクレオチド（ｉｒｏ）アンタゴニストによる自己免疫および炎症性疾患治療の強化 | |
| US8853375B2 (en) | Toll like receptor modulators | |
| JP7461872B2 (ja) | 脂質ナノ粒子製剤における使用のための脂質 | |
| JP7007304B2 (ja) | Ｂ型肝炎感染症治療用のＰＡＰＤ５又はＰＡＰＤ７のｍＲＮＡ減少用核酸分子 | |
| US9828601B2 (en) | Compositions for inhibiting checkpoint gene expression and uses thereof | |
| JP5813778B2 (ja) | トール様受容体に基づく免疫反応を調節するための免疫調節オリゴヌクレオチド（ｉｒｏ）化合物 | |
| CA2879066C (en) | Chiral nucleic acid adjuvant | |
| US10604760B2 (en) | Combination comprising immunostimulatory oligonucleotides | |
| JP5761911B2 (ja) | Ｔｌｒ７およびｔｌｒ８に対する安定化免疫調節ｒｎａ（ｓｉｍｒａ）化合物 | |
| JP4942646B2 (ja) | 免疫賦活オリゴヌクレオチドマルチマー | |
| KR102627418B1 (ko) | 변형된 올리고뉴클레오티드 및 사용 방법 | |
| US20110009477A1 (en) | Oligonucleotide-based compounds as inhibitors of toll-like receptors | |
| JP2013544816A5 (enExample) | ||
| CN102459302A (zh) | 核酸递送组合物及其使用方法 | |
| JP2015532097A5 (enExample) | ||
| KR101898177B1 (ko) | 톨－유사 수용체 기반 면역 반응을 조절하기 위한 면역 조절 올리고누클레오티드 （ｉｒｏ） 화합물 | |
| JP2022010100A (ja) | Ｈｉｖの治療のための手段 | |
| JP2011515357A5 (enExample) | ||
| JP2020521491A5 (enExample) | ||
| CN112840026B (zh) | 抑制tigit基因表达的组合物和方法 | |
| Kandimalla et al. | Springer-Verlag Berlin Heidelberg 2011 Published online: 3 August 2011 |